KesimptaConnect offers dedicated, personalised support to your patients who have been prescribed KESIMPTA®▼ (ofatumumab), and healthcare professionals throughout the KESIMPTA journey. The programme provides your patients who enrol in the programme with unique access to a wide range of services, including injection support, home deliveries, tailored information and interactive content covering wider aspects of living with RMS, as well as a dedicated, experienced nurse support team. The programme has been designed to offer personalised support in conjunction with the medical care provided by your hospital’s MS team.
KesimptaConnect consists of:
1. KesimptaConnect Homecare: in line with the National Homecare Medicines Committee (NHMC) Pharma-funded Homecare Services guidelines, Novartis has commissioned Lloyds Pharmacy Clinical Homecare Limited, Pharmaxo Pharmacy Services Limited and Sciensus Limited to provide a homecare service for patients prescribed KESIMPTA.
2. KesimptaConnect Nurse services: nurses who can provide virtual or face-to-face appointments with your patients to provide injection guidance and support in the first year of each patient’s treatment journey.
3. The KesimptaConnect App:* provides a hub of information and resources to your patient.
*At this time the KesimptaConnect App is in development and will be an option when formally available under the patient support programme.
KesimptaConnect Homecare and KesimptaConnect Nurse services are provided as a package deal and the KesimptaConnect App is a patient support programme, on behalf of Novartis Pharmaceuticals UK Ltd.
There is no obligation to use all elements of this programme, designed to allow you to choose the components that best suit the needs of your patient.
Discuss with your Novartis key account manager which elements are right for your patients and the MS services you provide.
KesimptaConnect is offered as a package deal and patient support programme, developed and funded by Novartis Pharmaceuticals UK Limited. KesimptaConnect is for NHS patients who are receiving KESIMPTA or for whom the prescribing decision has been made. A service level agreement is required for each NHS organisation participating.
Select the expand button above to view in full screen
MS=multiple sclerosis; NHS=National Health Service; NHMC=national homecare medicines committee; RMS=relapsing forms of multiple sclerosis.